Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 316 AL 330

The past, present, and future of Alzheimer's disease-part 3: the future

Nitrini R, Takada LT, Brucki SMD.

Arq Neuropsiquiatr. 2026 Jun;84(6):1-10. doi: 10.1055/s-0046-1824435. Epub 2026 Jul 14.

Baseline and placebo-related imaging, cerebrospinal fluid, plasma biomarker, and cognitive findings in unimpaired PSEN1 E280A mutation carriers and non-carriers in the Alzheimer's Prevention Initiative Autosomal Dominant Alzheimer's Disease Colombia Trial

Bittner T, Lopera F, Rios-Romenets S, Schiffman C, Clayton D, Hibar D, Kollmorgen G, Dolton M, Poon V, Nguyen J, Giraldo-Chica M, Acosta-Baena N, Espinosa A, Villegas G, Muñoz C, Serna L, Alvarez S, Protas H, Luo J, Sohankar J, Chen Y, Ghisays V, Malek-Ahmadi M, Ashton NJ, Denkinger MN, Cai Y, Xu YR, Ostaszewski B, Selkoe DJ, Alexander RC, Quiroz YT, Su Y, Chen K, Doody RS, Langbaum JB, Tariot PN, Sink KM, Reiman EM.

EBioMedicine. 2026 Aug;130:106390. doi: 10.1016/j.ebiom.2026.106390. Epub 2026 Jul 17.

Neurotheranostics in Alzheimer's Disease: Current concepts and experimental strategies

Yanagisawa D, Ohgita T, Kawashima H, Yoshikawa H, Saito H, Tooyama I, Takata K.

Pharmacol Ther. 2026 Oct;286:109084. doi: 10.1016/j.pharmthera.2026.109084. Epub 2026 Jul 19.

Efficacy Measures Used in Alzheimer Disease Clinical Trials Between 2015 and 2025: A Systematic Review

Li C, Fu M, Berg K, Wallach J, Ling K, Wei R, Shi L, Ross J, Guan X.

Neurology. 2026 Aug 25;107(4):e218373. doi: 10.1212/WNL.0000000000218373. Epub 2026 Jul 23.

Role of Exercise in Cardiovascular Disease and Alzheimer's Disease Comorbidity: A Blood Biomarker Perspective

Lu Y, Xu C, Fu P, Gong L.

Cells. 2026 Jul 17;15(14):1284. doi: 10.3390/cells15141284.

Pharmacological and Clinical Heterogeneity of Anti-Amyloid Monoclonal Antibodies in Early Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Trials

Vamanu A, Mastaleru A, Schreiner TG, Popescu G, Roceanu AM, Cucu AI, Patrascu A, Vulpoi GA, Bilcu RV, Cozma RS, Olariu R, Bistriceanu CE, Covali R, Cuciureanu DI, Ciubotaru A.

Med Sci (Basel). 2026 Jun 23;14(3):337. doi: 10.3390/medsci14030337.

Biomarker-Based Diagnosis and Care Pathways for Alzheimer's Disease in the Era of Disease-Modifying Treatments: A Consensus Statement by Belgian Experts

Van Langenhove T, Van Mossevelde S, Miatton M, De Lepeleire J, Bruffaerts R, Bier JC, Segers K, Verschraegen J, Petrovic M, Ventura M, Jedidi H, Beyer I, Mormont E, Vandenberghe R, Delva A, Gilles C, Van Weehaeghe D, Picard G, De Deyn P, Strauss M, Thiery E, Salmon E, Cypers G, Vlaemynck J, Gillis K, Versijpt J, Bjerke M, Sieben A, Hanseeuw B, Engelborghs S, Deryck O; BeDeCo members.

Eur J Neurol. 2026 Aug;33(8):e70668. doi: 10.1111/ene.70668.

Lecanemab use in Chinese patients with Alzheimer's disease: a 12-month multicenter real-world study

Wu H, Chen Q, Fang M, Tang H, Liu H, Liu J, Zhang J, Chi L, Liu S, Xin J, Leng L, Wang P, Chi S, Li Y, Chen J, Zhang L, Zhang J, Ma Q, Wang X, Meng X, Nao J, Li X, Lv Y, Jia Y, Zhao Q, Liu C, Gan J, Zhu J, Song Y, Li H, Fei M, Guo X, Liu J, Peng G, Chen X, Ji Y.

Alzheimers Dement. 2026 Aug;22(8):e71702. doi: 10.1002/alz.71702.

Mechanisms, Biomarkers and Therapeutic Implications of Neuroinflammation in Alzheimer's Disease

Papelian S.

Int J Dev Neurosci. 2026 Aug;86(5):e70168. doi: 10.1002/jdn.70168.

A randomized phase 1b/2 trial of ABBV-916 in adults with early Alzheimer's disease

Lynch SY, Wang Y, Wang D, Bachhav SS, Xiong H, Boiser J, Stage E, Bannon AW, Graff O, Florian H.

Alzheimers Dement. 2026 Aug;22(8):e71715. doi: 10.1002/alz.71715.

Plasma P-tau217 for detecting amyloid clearance after donanemab in Alzheimer's disease

Collins EC, Lu M, Beck R, Hendrix J, Hodsdon ME, Hansson O.

Alzheimers Dement. 2026 Aug;22(8):e71740. doi: 10.1002/alz.71740.

Multi-Targeting Ligands as Prospective Therapeutics for Alzheimer's Disease, a Prevalent Neurodegenerative Disorder: Mechanistic Insights, Emerging Targets and Drug Discovery Campaigns

Thakur A, Rana M, Vanjani S, Liou KC, Taliyan R, Nepali K, Yang CH.

Med Res Rev. 2026 Jul;46(4):1173-1229. doi: 10.1002/med.70047. Epub 2026 Apr 19.

Experimental and translational models of Alzheimer's disease: From neurodegeneration to novel therapeutic insights

Khan N, De S, Boddu S, Pravala N.

J Prev Alzheimers Dis. 2026 Apr;13(4):100498. doi: 10.1016/j.tjpad.2026.100498. Epub 2026 Jan 30.

Neuroimmune dysregulation in Alzheimer's disease: Mechanisms and therapeutic strategies

He H, Zhu S, Zhang C, Wang H, Li Y, Qian H.

Ageing Res Rev. 2026 May;117:103055. doi: 10.1016/j.arr.2026.103055. Epub 2026 Feb 5.

Exploring the Potential of Herbal Compounds as Autophagy Modulators in Alzheimer's Disease: A Comprehensive Review

Yadav E, Mandal AK, Sah AK, Poudel S, Pathak P, Khalilullah H, Jaremko M, Emwas AH, Yadav P, Verma A.

CNS Neurol Disord Drug Targets. 2026;25(2):78-103. doi: 10.2174/0118715273298025240905130205.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias